0001209191-21-045423.txt : 20210706
0001209191-21-045423.hdr.sgml : 20210706
20210706161447
ACCESSION NUMBER: 0001209191-21-045423
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170701
FILED AS OF DATE: 20210706
DATE AS OF CHANGE: 20210706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horn David R.
CENTRAL INDEX KEY: 0001834217
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39747
FILM NUMBER: 211074240
MAIL ADDRESS:
STREET 1: 3800 BRIDGE PARKWAY
STREET 2: SUITE 102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seer, Inc.
CENTRAL INDEX KEY: 0001726445
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 821153150
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3800 BRIDGE PARKWAY, SUITE 102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-453-0000
MAIL ADDRESS:
STREET 1: 3800 BRIDGE PARKWAY, SUITE 102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Seer Biosciences, Inc.
DATE OF NAME CHANGE: 20171226
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-01
0
0001726445
Seer, Inc.
SEER
0001834217
Horn David R.
C/O SEER, INC.
3800 BRIDGE PARKWAY, SUITE 102
REDWOOD CITY
CA
94065
0
1
0
0
Chief Financial Officer
Class A Common Stock
2021-07-01
4
M
0
10000
2.70
A
240966
D
Class A Common Stock
2021-07-01
4
S
0
4989
30.5113
D
235977
D
Class A Common Stock
2021-07-01
4
S
0
2500
31.6297
D
233477
D
Class A Common Stock
2021-07-01
4
S
0
2511
32.6335
D
230966
D
Employee Stock Option (right to buy)
2.70
2021-07-01
4
M
0
10000
0.00
D
2030-04-01
Class A Common Stock
10000
606547
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.03 to $31.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.06 to $32.05, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.10 to $32.99, inclusive.
The shares underlying the option are subject to an early exercise provision and are immediately exercisable. One-fourth of the shares underlying the option vested on April 1, 2021 and 1/48th of the shares vest monthly thereafter.
/s/ David R. Horn
2021-07-06